Professor Nick Alderman

Elysium Neurological, Elysium Healthcare

Professor Nick Alderman BA (Hons) MAppSci PhD CPsychol CSci FBPsS
Professor Nick Alderman is Clinical Director, Neurobehavioral Rehabilitation Services at Elysium Neurological, part of Elysium Healthcare. He is acknowledged internationally as one of the foremost experts in neurobehavioral rehabilitation, having combined successful careers in both clinical and academic psychology.

Previously he held senior posts at St Andrew’s Healthcare (Kemsley Unit), the Brain Injury Rehabilitation Trust, Partnerships in Care and Priory Healthcare. He is Honorary Professor at Swansea University and Visiting Professor at the University of the West of England. In addition, Nick is Chair of the Independent Neurorehabilitation Providers Alliance ‘Research & Outcomes’ group, and Chair of the East Midlands Acquired Brain Injury Forum. Nick has published numerous journal papers and book chapters; has created neuropsychological tests, observational recording measures and outcome measures used in neurorehabilitation services across the world.

He has received many awards in recognition of his work, including the prestigious United Kingdom Acquired Brain Injury Forum ‘Stephen McAleese Award for Inspiration’ in recognition of his work in successfully reducing restrictive interventions in neurobehavioral rehabilitation. Nick is a keen dog owner and prides himself on being an amateur musician of ‘questionable talent’.

dont miss

Untangling the mystery of how to measure neurobehavioral disability: SASNOS

Neurobehavioral disability (NBD) resulting from acquired brain injury has significant consequences, underpinning challenging behaviour, which is known to be the greatest impediment to community integration. Effective management of NBD increases personal autonomy through reduction of social handicap. However, assessment of NBD has proved problematic, principally because symptoms constitute a diverse, complex, subtle, and pervasive constellation of cognitive-behavioural changes. Standardised measures of NBD have been compiled but suffer from shortcomings that undermine their usefulness. To provide a ‘fit-for-purpose’ assessment tool, the ‘St Andrew’s - Swansea Neurobehavioral Assessment Scale’ (SASNOS) was developed and is available free of charge. In this seminar, attendees will become aware of why and how SASNOS was developed, learn how it is completed, and become familiar with its numerous applications, in particular, how it benefits clinical practice. Finally, progress to date in developing a revised, expanded version of SASNOS in response to user feedback will be shared.

EVEN MORE SEMINARS

  • Dr Camilla Nord: Speaking at the European Neurological Convention

    Dr Camilla Nord
    University of Cambridge

    Neurobiological predictors of response to tDCS-enhanced psychological therapy in depression

  • Dr Nicholas Silver: Speaking at the European Neurological Convention

    Dr Nicholas Silver
    The Walton Centre for Neurology and Neurosurgery, Liverpool; The Brain Charity

    More than just a headache, more than just prescribing drugs

  • Bridget Churchill: Speaking at the European Neurological Convention

    Bridget Churchill
    Medifab

    Reflections on the challenges of seating solutions for Neurological clients with complex postures and their impact on function.

  • Martin Knight MD FRCS MBBS: Speaking at the European Neurological Convention

    Martin Knight MD FRCS MBBS
    The Spinal Foundation

    Indications and long-term outcomes for Transforaminal Endoscopic Lumbar Decompression and Foraminoplasty (TELDF)

  • NECHAMA KARMAN: Speaking at the European Neurological Convention

    NECHAMA KARMAN
    MOBILITY RESEARCH UK

    Braking Bad: Developing Eccentric Control in Clients with CNS Dysfunction